NYSE: MTDMettler Toledo International Inc Stock
$1,155.42-32.79 (-2.76%)
Updated Jun 13, 2025
MTD Price
$1,155.42
Fair Value Price
N/A
Market Cap
$24.01B
52 Week Low
$946.69
52 Week High
$1,546.93
P/E
28.72x
P/B
-131.95x
P/S
6.43x
PEG
3.96x
Dividend Yield
N/A
Revenue
$3.83B
Earnings
$849.22M
Gross Margin
60.1%
Operating Margin
28.48%
Profit Margin
22.2%
Debt to Equity
-18.78
Operating Cash Flow
$973M
Beta
1.1
Next Earnings
Jul 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
MTD Overview
Mettler-Toledo International Incorporated manufactures laboratory instruments including liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments. It also offers LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its Retail Weighing solutions also offers networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. Mettler-Toledo International was incorporated in 1991 and is headquartered in Columbus, OH.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MTD's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important MTD news, forecast changes, insider trades & much more!
MTD News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MTD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MTD ($1,155.42) is trading above its intrinsic value of $324.35, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MTD is good value based on its earnings relative to its share price (28.72x), compared to the US market average (31.36x)
P/E vs Market Valuation
MTD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more MTD due diligence checks available for Premium users.
Valuation
MTD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
28.72x
Industry
19.9x
Market
31.36x
MTD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MTD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MTD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-131.95x
Industry
3.47x
MTD price to earnings growth (PEG)
For valuing profitable companies with growth potential
MTD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MTD's financial health
Profit margin
Revenue
$883.7M
Net Income
$163.6M
Profit Margin
18.5%
MTD's Earnings (EBIT) of $1.09B... subscribe to Premium to read more.
Interest Coverage Financials
MTD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.2B
Liabilities
$3.4B
Debt to equity
-18.78
MTD's short-term assets ($1.16B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MTD's long-term liabilities ($2.27B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MTD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MTD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$194.4M
Investing
-$6.9M
Financing
-$184.1M
MTD's operating cash flow ($972.81M)... subscribe to Premium to read more.
Debt Coverage Financials
MTD vs Diagnostic & Research Stocks
Mettler Toledo International Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.